Schizotypal disorder and cenestho-hypochondriac syndrome (place of sulpiride in the therapy)
The article is devoted to the treatment of patients with schizotypal disorder. Authors tell about their experience with atypical antipsychotics (sulpiride) in the treatment of patients with sluggish schizophrenia.
Main Authors: | M. A. Parpara, A. E. Bobrov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/570 |
Similar Items
-
Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders
by: Nina Arkadyevna Tyuvina, et al.
Published: (2012-03-01) -
Association between mechanisms of psychological adaptation and cognitive functioning violation in patients with schizotypal disorder
by: A. V. Stepanova, et al.
Published: (2018-07-01) -
Development spectrofotometric of the technique of analysis risperidon in tablets and it validation
by: I P Remezova
Published: (2010-12-01) -
Adverse ocular effects of neuroleptic therapy: semiotics, pathogenesis and treatment
by: A. A. Panov, et al.
Published: (2022-01-01) -
News about medicine affect compliance in people with hypochondriac beliefs
by: S. Kumchenko, et al.
Published: (2021-04-01)